Shumpei Yokota

Summary

Affiliation: Yokohama City University
Country: Japan

Publications

  1. ncbi Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy
    S Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Kanagawa, Japan
    Pediatr Int 42:197-203. 2000
  2. ncbi Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 23:425-9. 2013
  3. ncbi Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 22:491-7. 2012
  4. ncbi Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
    Takako Miyamae
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawaku, Yokohama 236 0004, Japan
    Pediatr Rheumatol Online J 8:6. 2010
  5. ncbi Effect of anakinra on arthropathy in CINCA/NOMID syndrome
    Takako Miyamae
    Department of Pediatrics, Yokohama City University, Yokohama, Japan
    Pediatr Rheumatol Online J 8:9. 2010
  6. ncbi A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness
    Asako Fujitsuka
    Department of Pediatrics, National Hospital Organization Yokohama Medical Center, 3 60 2 Harajuku, Totsuka ku, Yokohama, Kanagawa 245 8575, Japan
    BMC Infect Dis 11:168. 2011
  7. ncbi Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy
    Takako Miyamae
    Division of Rheumatology, Children s Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Arthritis Res Ther 7:R746-55. 2005
  8. ncbi Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 20:107-13. 2010
  9. ncbi Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Yokohama City University School of Medicine, Kanagawa, Japan
    Arthritis Rheum 52:818-25. 2005
  10. ncbi Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Kanazawa Ku, Yokohama, Kanagawa, Japan
    Expert Rev Clin Immunol 6:735-43. 2010

Detail Information

Publications119 found, 100 shown here

  1. ncbi Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy
    S Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Kanagawa, Japan
    Pediatr Int 42:197-203. 2000
    ..To establish a treatment strategy for acute encephalopathy and encephalitis associated with influenza virus infection, the pathophysiology of the disease was investigated through manifestations and laboratory findings of patients...
  2. ncbi Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 23:425-9. 2013
    ..This guidance describes the use of canakinumab in Japan for CAPS in relation to exclusion criteria, method of use, evaluation criteria, and adverse drug reactions...
  3. ncbi Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 22:491-7. 2012
    ..The guidance presented here define the indications, exclusion criteria, usage, and evaluation criteria of adalimumab for the treatment of polyarticular JIA...
  4. ncbi Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
    Takako Miyamae
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawaku, Yokohama 236 0004, Japan
    Pediatr Rheumatol Online J 8:6. 2010
    ..08 mg/dL. Recent examination by whole-body 18F-FDG-PET-CT over the 15 months of thalidomide treatment demonstrated fewer hot spots around the subcutaneous calcified lesions...
  5. ncbi Effect of anakinra on arthropathy in CINCA/NOMID syndrome
    Takako Miyamae
    Department of Pediatrics, Yokohama City University, Yokohama, Japan
    Pediatr Rheumatol Online J 8:9. 2010
    ..Furthermore, longitudinal growth of the femur and tibia was identified during 20 months of observation...
  6. ncbi A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness
    Asako Fujitsuka
    Department of Pediatrics, National Hospital Organization Yokohama Medical Center, 3 60 2 Harajuku, Totsuka ku, Yokohama, Kanagawa 245 8575, Japan
    BMC Infect Dis 11:168. 2011
    ..Recent studies strongly suggest that some respiratory viruses are associated with the induction of acute wheezing and/or exacerbation of bronchial asthma. However, molecular epidemiology of these viruses is not exactly known...
  7. ncbi Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy
    Takako Miyamae
    Division of Rheumatology, Children s Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Arthritis Res Ther 7:R746-55. 2005
    ....
  8. ncbi Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 20:107-13. 2010
    ..The guidelines presented here define the indications, exclusion criteria, usage, and evaluation criteria of etanercept for the treatment of polyarticular JIA...
  9. ncbi Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Yokohama City University School of Medicine, Kanagawa, Japan
    Arthritis Rheum 52:818-25. 2005
    ....
  10. ncbi Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Kanazawa Ku, Yokohama, Kanagawa, Japan
    Expert Rev Clin Immunol 6:735-43. 2010
    ..Thus, tocilizumab is generally safe and well tolerated. It might be a suitable treatment in the control of this disorder, which has so far been difficult to manage...
  11. ncbi Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    Clin Rev Allergy Immunol 28:231-8. 2005
    ..A confirmation of the role of tocilizumab in the treatment of sJIA will be provided by the results of the ongoing phase III study in Japan...
  12. ncbi Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicines, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 14:12-7. 2004
    ..MRA could be a therapeutic modality for children with systemic-onset JIA intractable to high-dose corticosteroids...
  13. ncbi Guidance on using tocilizumab for juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 21:563-71. 2011
    ....
  14. ncbi Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Kanagawa, Japan
    Curr Opin Rheumatol 15:581-6. 2003
    ....
  15. ncbi Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007)
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 17:353-63. 2007
    ..Finally, we hope that this guidance will trigger exploration for further information by referring to the textbooks and literature listed at the end of these guidelines...
  16. ncbi Mizoribine: mode of action and effects in clinical use
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    Pediatr Int 44:196-8. 2002
    ..Thus, mizoribine is superior to azathioprine, in that it may not cause damages to normal cells and normal nucleic acid...
  17. ncbi Foreword--Mizoribine: a new immunosuppressive drug for kidney diseases and rheumatic diseases
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    Pediatr Int 44:195. 2002
  18. ncbi Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
    Shumpei Yokota
    Department of Paediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Lancet 371:998-1006. 2008
    ..We investigated the efficacy and safety of tocilizumab, an anti-interleukin-6-receptor monoclonal antibody, in children with this disorder...
  19. ncbi Interleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosus
    Shiho Iwasaki
    Department of Pediatrics, Yokohama City University, Yokohama 236 0004, Japan
    Pediatr Res 62:392-8. 2007
    ..Accordingly, IL-15 might have an inhibitory effect on the physiologic vascular remodeling processes in closing the DA...
  20. ncbi Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan
    Masaaki Mori
    Department of Pediatrics, Yokohama City University Medical Center, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Mod Rheumatol 22:720-6. 2012
    ..The aim of this study was to evaluate the long-term safety and efficacy of etanercept in Japanese children with JIA...
  21. ncbi Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    J Clin Immunol 31:946-51. 2011
    ..IRF5 acts as a master transcription factor in the activation of pro-inflammatory cytokines. We assessed associations of IRF5 gene polymorphisms with susceptibility to secondary HLH...
  22. ncbi Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Tokyo, Japan
    Clin Transplant 24:855-61. 2010
    ..CNIs are substrates for CYP3A5 and P-glycoprotein (P-gp), encoded by ABCB1 gene. In the present study, we hypothesized that genetic variability in CYP3A5 and ABCB1 genes may be associated with CNI-related neurotoxicity...
  23. ncbi Comparison of markers for fetal inflammatory response syndrome: fetal blood interleukin-6 and neonatal urinary beta(2)-microglobulin
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    J Obstet Gynaecol Res 35:472-6. 2009
    ..The aim of the present study was to compare the value of measuring neonatal urinary beta(2)-microglobulin (beta(2)-MG) levels with fetal blood interleukin (IL)-6 levels in premature infants at risk of developing CLD...
  24. ncbi [Effects of therapies on childhood systemic lupus erythematosus]
    Rumiko Kurosawa
    Department of Pediatrics, Yokohama City University School of Medicine
    Ryumachi 43:632-7. 2003
    ..In conclusion, the combination of immunosuppressants and IVCY appeared to offer great benefits in childhood systemic lupus erythematosus...
  25. ncbi [Three cases of childhood-onset male systemic lupus erythematosus (SLE) successfully treated with a combination of pulse methylprednisolone and pulse cyclophosphamide]
    Shoko Nakajima
    Department of Pediatrics, Yokohama City University School of Medicine
    Nihon Rinsho Meneki Gakkai Kaishi 28:343-8. 2005
    ..We suggest a combination of pulse mPSL and IVCY is effective for the patients who are suffering with severe lupus nephritis complicated with the other collagen diseases...
  26. ncbi Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Tomoyuki Imagawa
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa 236 0004, Japan
    Mod Rheumatol 22:109-15. 2012
    ..In conclusion, tocilizumab showed early and sustained efficacy and tolerability for treating intractable pJIA, which suggests that it is a promising new treatment for this disease...
  27. ncbi Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
    Masaaki Mori
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 19:1-11. 2009
    ..It also merits attention that the maximum dose (10 mg/m2) was set on the basis of pharmacokinetic data from children, rather than relying on the dosing method and dose for adults...
  28. ncbi Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells
    Shoko Nakajima
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa 236 0004, Japan
    Cytokine 47:91-7. 2009
    ....
  29. ncbi Suppressed neutrophil function in children with acute lymphoblastic leukemia
    Fumiko Tanaka
    Department of Pediatrics, Yokohama City University Hospital, 3 9 Fukuura Kanazawa ku, Yokohama, Japan
    Int J Hematol 90:311-7. 2009
    ..Impaired oxidative burst of neutrophils may be one risk factor for infections in children with ALL, especially in the initial periods of treatment...
  30. ncbi [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody]
    Takako Miyamae
    Department of Pediatrics, Yokohama City University
    Nihon Rinsho Meneki Gakkai Kaishi 31:405-14. 2008
    ....
  31. ncbi Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence
    Shuichi Ito
    Children s Medical Center, Yokohama City University Medical Center, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Pediatr Nephrol 24:411-4. 2009
    ..Our treatment of this patient shows that treatment with MZR can allow steroid sparing and prevent recurrence in a patient with sarcoidosis...
  32. ncbi Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants
    Hiromi An
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Am J Obstet Gynecol 191:1649-54. 2004
    ..In order to predict the late-development of chronic lung disease of prematurity (CLD), cytokines in the cord blood were assessed in this study...
  33. ncbi Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
    Shoko Nakajima
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 19:42-6. 2009
    ....
  34. ncbi Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanazawa Ku, Yokohama 236 0004, Japan
    Br J Clin Pharmacol 71:237-43. 2011
    ..We investigated whether several polymorphisms within the methotrexate (MTX) pathway genes were related to the toxicity and efficacy of MTX in 92 Japanese patients with articular-type juvenile idiopathic arthritis (JIA)...
  35. ncbi Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    J Hum Genet 56:196-9. 2011
    ..We also found an association between HLA-DRB1(*)04:05 and polyarticular JIA. Thus, clinical subtypes of JIA can be classified by the presence of the specific HLA alleles, HLA-A(*)02:06 and DRB1(*)04:05...
  36. ncbi Soluble tumor necrosis factor receptor-1 in preterm infants with chronic lung disease
    Miho Sato
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    Pediatr Int 52:268-72. 2010
    ..The purpose of the present study is to investigate changes of serum soluble tumor necrosis factor receptor-1 levels over time in infants with chronic lung disease...
  37. ncbi Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University Graduate School of Medicine and the CNV Laboratory, DNA Chip Research Institute, Yokohama, Japan
    J Rheumatol 38:769-74. 2011
    ..Our aim was to assess associations of IRF5 gene polymorphisms with susceptibility to systemic JIA and MAS...
  38. ncbi Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis
    Hiroyuki Machida
    Department of Pediatrics, Yokohama City University, Japan
    Nephrol Dial Transplant 25:2530-537. 2010
    ..We conducted a study to elucidate the association between TLR9 and LN in childhood-onset SLE...
  39. ncbi [A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis]
    Shoko Nakajima
    Department of Pediatrics, Yokohama City University of Medicine, Yokohama, Japan
    Nihon Rinsho Meneki Gakkai Kaishi 28:154-8. 2005
    ..The histology of liver biopsy specimen was useful for the diagnosis of AIH in such a difficult case needed to be differentiated from EBV hepatitis...
  40. ncbi [Cyclophosphamide pulse therapy for pediatric systemic sclerosis]
    Naomi Iwata
    Department of Pediatrics and Dermatology, Yokohama City University School of Medicine, Yokohama, Japan
    Ryumachi 43:660-6. 2003
    ..We further observed that their total skin score was decreasing while the clinical manifestations improved...
  41. ncbi [A case of systemic scleroderma complicating pulmonary hypertension]
    Rumiko Kurosawa
    Department of Pediatrics, Yokohama City University School of Medicine
    Nihon Rinsho Meneki Gakkai Kaishi 29:378-83. 2006
    ..The dermal symptoms improved, and it was possible to maintain a state of remission...
  42. ncbi [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation]
    Masakatsu Yanagimachi
    Department of Pediatrics, Yokohama City University School of Medicine
    Rinsho Ketsueki 49:99-103. 2008
    ..The cutaneous lesions gradually improved after continuous administration of CAM. Cutaneous NTM infection is rare, but it may occur in immunocompromised patients after SCT...
  43. ncbi Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children
    Hiroaki Goto
    Department of Pediatrics, Yokohama City University Hospital, 3 9 Fukuura Kanazawa ku, Yokohama 236 0044, Japan
    Leuk Res 33:1386-91. 2009
    ..22-1.8 microg/ml and 0.57-3.6 ng/ml, respectively. This cell line panel offers an in vitro model for the development of new therapies for childhood BCP-ALL...
  44. ncbi Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia
    Hiroaki Goto
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Anticancer Drugs 23:417-25. 2012
    ..However, combination therapy with DMF and other anticancer drugs is not recommended...
  45. ncbi Urinary ß2-microglobulin in very preterm neonates with chorioamnionitis
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Pediatr Nephrol 26:2185-91. 2011
    ..It is suggested that the urinary β(2)-MG level during the early postnatal period can identify prenatal inflammation...
  46. ncbi Acute pancreatitis associated with systemic lupus erythematosus: Successful treatment with plasmapheresis followed by aggressive immunosuppressive therapy
    Norio Tominaga
    Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki, Japan
    Pediatr Int 50:109-11. 2008
  47. ncbi [Gastrointestinal involvement and renal infarction in a boy with classic polyarteritis nodosa diagnosed with 3D-computed tomography angiography]
    Fumie Sano
    Department of Pediatrics, Yokohama City University
    Nihon Rinsho Meneki Gakkai Kaishi 31:415-21. 2008
    ....
  48. ncbi Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation
    Reo Tanoshima
    Department of Pediatrics, Yokohama City University, Yokohama, Kanagawa, Japan
    Pediatr Blood Cancer 50:665-7. 2008
    ..She has been in complete remission for 1 year after transplantation. This case illustrates that CBT can provide a potent graft versus leukemia (GVL) effect against JMML...
  49. ncbi Whole blood interferon-gamma assay for tuberculosis in children in Japan
    Rumiko Higuchi
    Department of Pediatrics, Yokohama City University, Yokohama, Kanagawa, Japan
    Pediatr Int 51:97-102. 2009
    ..The aim of the present study was to assess the usefulness of QFT-2G as an indicator, both for diagnosing childhood TB and for assessing therapeutic effectiveness...
  50. ncbi [Juvenile rheumatoid arthritis]
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine
    Nippon Rinsho 63:274-80. 2005
  51. ncbi Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
    Tomoyuki Imagawa
    Yokohama City University, Japan
    Clin Rheumatol 31:1713-21. 2012
    ..In pediatric patients with polyarticular JIA in Japan, adalimumab was safe and effective for reducing disease activity for up to 60 weeks...
  52. ncbi Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series
    Masaaki Mori
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa 236 0004, Japan
    J Rheumatol 39:864-7. 2012
    ..Plasma exchange (PE) was available as a rescue therapy for patients refractory to infliximab...
  53. ncbi Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis
    Remi Ozawa
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 22:558-64. 2012
    ....
  54. ncbi Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general
    Masaaki Mori
    Department of Pediatrics, Yokohama City University Medical Center, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Mod Rheumatol 21:449-57. 2011
    ..Consequently, IVCY is now available for the treatment of both childhood and adult rheumatic diseases in general...
  55. ncbi Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury
    Yoshinori Kobayashi
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Pediatr Int 46:685-92. 2004
    ..The detection of plasma cytochrome c levels may be a useful clinical tool for the detection of apoptosis in vivo...
  56. ncbi [Biologic response modifiers for juvenile idiopathic arthritis]
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine
    Nihon Rinsho 65:1331-5. 2007
    ..Recently, IL-1Ra was reported to be effective for these children. Moreover, tocilizumab, anti-IL-6 receptor monoclonal antiboby developed in Japan, was revealed to be effective and safe...
  57. ncbi Maternal vitamin A alters gene profiles and structural maturation of the rat ductus arteriosus
    Utako Yokoyama
    Department of Physiology, Yokohama City University, Yokohama, Japan
    Physiol Genomics 31:139-57. 2007
    ..The present study indicates that MVA-mediated alteration in gene profile was associated with early structural maturation of DA, although MVA-mediated maturation may differ from normal vascular remodeling of DA...
  58. ncbi Plasma exchange for refractory Kawasaki disease
    Tomoyuki Imagawa
    Department of Paediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, 236-0004 Yokohama, Japan
    Eur J Pediatr 163:263-4. 2004
  59. ncbi [Two female siblings with childhood-onset systemic lupus erythematosus]
    Fumie Sano
    Department of Pediatrics, Yokohama City University School of Medicine, Japan
    Nihon Rinsho Meneki Gakkai Kaishi 31:172-7. 2008
    ..HLA typing was performed and the siblings were noted to have the same haplotype; A(*)0207, A(*)2402, B(*)4601, B(*)5201, B(*)5201, Cw(*)0102, Cw(*)1202, DRB1(*)0101, DRB1(*)0803...
  60. ncbi [A case report of childhood systemic lupus erythematosus complicated with lupus cystitis]
    Rumiko Kurosawa
    Department of Pediatrics, Yokohama City University School of Medicine
    Nihon Rinsho Meneki Gakkai Kaishi 29:154-9. 2006
    ..We reported a case of childhood SLE complicated with lupus cystitis and successfully treated by IVCY-pulse therapy and maintenance predonisolone and azathioprin...
  61. ncbi Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection
    Motohiko Okano
    Department of Pediatrics, Hokkaido University Hospital, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Am J Hematol 80:64-9. 2005
    ..Guidelines, derived mainly from the current literature and recent experiences with CAEBV in Japan, for diagnosing CAEBV are proposed to clarify this enigmatic disease...
  62. ncbi [Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis]
    Utako Kaneko
    Department of Pediatrics, Yokohama City University School of Medicines, Yokohama, Japan
    Nihon Rinsho Meneki Gakkai Kaishi 33:317-23. 2010
    ..Infliximab would be a good choice for adolescent patients with TA refractory to conventional treatments. However, we should carefully monitor safety and efficacy of this agent considering its peculiarity...
  63. ncbi The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis
    Akitaka Takahashi
    Department of Pediatrics, Yokohama City University School of Medicine, Kanazawa Ku, Yokohama, Kanagawa, Japan
    Mod Rheumatol 19:302-8. 2009
    ..Further study will be necessary to elucidate the mechanism of HO-1 production and to clarify the role of HO-1 in the disease process...
  64. ncbi [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation]
    Fumiko Kuroki
    Department of Pediatrics, Yokohama City University School of Medicine
    Rinsho Ketsueki 47:639-44. 2006
    ..In both these cases, the results suggest that using PBSC as a stem cell source and abrupt cessation of GVHD prophylaxis provided a potent graft-versus-leukemia effect...
  65. ncbi A report of two cases of Kawasaki disease treated with plasma exchange
    Tomonori Harada
    Children s Medical Center, Yokohama City University Medical Center, Yokohama, Japan
    Ther Apher Dial 12:176-9. 2008
    ..In both cases, plasma exchange may have reduced the risk of coronary artery lesions and proved effective against acute heart failure with catecholamine-refractory shock; yet the mechanism of this improvement remains unclear...
  66. ncbi Hyper-IgD syndrome with novel mutation in a Japanese girl
    Takuya Naruto
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Mod Rheumatol 19:96-9. 2009
    ..This is the first case in which homozygosity for the mutation of the MVK gene has been reported in an Asian patient, and indicated a need for differentiation...
  67. ncbi Survey of psychological support for bereaved families in Japan
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University, School of Medicine, Kanagawa, Japan
    Pediatr Int 51:626-9. 2009
    ..The aim of the present study was to investigate the current conditions of psychological support for the families of children who died suddenly of disease or accident...
  68. ncbi [Sjögren's syndrome associated with childhood-onset systemic lupus erythematosus]
    Naomi Iwata
    Department of Pediatrics, Yokohama City University, Japan
    Nihon Rinsho Meneki Gakkai Kaishi 31:166-71. 2008
    ..The revised criteria is useful for diagnosis of SS in early stage before the development of exocrine gland damage and appears to be helpful for long term follow-up in childhood-onset SLE associated with SS...
  69. ncbi Cross-cultural adaptation and validation of the Japanese version of the Childhood Health Assessment Questionnaire (CHAQ)
    Takako Miyamae
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawaku, Yokohama 236 0004, Japan
    Mod Rheumatol 18:336-43. 2008
    ..Functional ability, as assessed by the CHAQ, may not be the main consideration of sJIA patients' parents when assessing their child's status...
  70. ncbi Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells
    Hiroaki Goto
    Department of Pediatrics, Yokohama City University Hospital, 3 9 Fukuura Kanazawa ku, Yokohama 236 0044, Japan
    Leuk Res 31:1293-301. 2007
    ..BSO up-regulated Bcl-2 protein, and antagonized the anti-ALL effect of prednisolone in BSO-resistant cells. A lack of mitochondrial death-signal activation by oxidative stress seemed to be associated with BSO-resistance in ALL...
  71. ncbi Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma
    Sakurako Izaki
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Int J Hematol 86:253-60. 2007
    ..The effectiveness of the BVL regimen requires further study...
  72. ncbi HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis
    Noriaki Tomono
    Division of Immunology and Rheumatology, Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    J Rheumatol 31:1847-50. 2004
    ..To investigate HLA molecules and genes in Japanese patients with juvenile dermatomyositis (JDM)...
  73. ncbi Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin
    Masaaki Mori
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fuku ura, Kanazawa Ku, Yokohama, 236 0004, Japan
    Mod Rheumatol 14:43-7. 2004
    ..PE should be performed at an early stage, as soon as fractional increases in inflammatory markers are found after IVGG therapy...
  74. ncbi A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine
    Toshiyuki Sugai
    Department of Pediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa 236 0004, Japan
    Vaccine 23:5450-6. 2005
    ..These data suggested new applications of CpG-ODN as adjuvants in DPT vaccine...
  75. ncbi Early discharge from a neonatal intensive care unit and rates of readmission
    Kazuo Seki
    Perinatal Center for Maternity and Neonate, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Int 53:7-12. 2011
    ..We studied the real state of this strategy...
  76. ncbi Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone
    Yukoh Aihara
    Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Int 49:659-62. 2007
  77. ncbi Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus
    Yukoh Aihara
    Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Int 44:199-204. 2002
    ..Therefore, we have been attempting to improve the maintenance therapy of child-onset SLE...
  78. ncbi Norovirus-associated encephalopathy
    Shuichi Ito
    Children s Medical Center, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Infect Dis J 25:651-2. 2006
    ..This is the first report of encephalopathy potentially caused by norovirus as indicated by the presence of the virus genome in CSF...
  79. ncbi Successful bone marrow transplantation for severe aplastic anemia in a patient with persistent human parvovirus B19 infection
    Hiroaki Goto
    Department of Pediatrics, Yokohama City University School of Medicine, Japan
    Int J Hematol 79:384-6. 2004
    ..B19 DNA disappeared from the serum 2 months after BMT, suggesting that a normal immune response was restored by BMT and terminated the B19 viremia. During BMT, use of high-titer IVIg for B19 might prevent B19-associated organ failure...
  80. ncbi Hemimegalencephaly misdiagnosed as a congenital brain tumor by fetal cerebral ultrasonography
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    Prenat Diagn 24:257-9. 2004
    ..To describe a case of hemimegalencephaly misdiagnosed prenatally...
  81. ncbi Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan
    Masaaki Mori
    Department of Pediatrics, Yokohama City University Medical Center, 4 57 Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    J Infect Chemother 17:254-63. 2011
    ....
  82. ncbi PET assessment of disease activity in children with juvenile idiopathic arthritis
    Ukihide Tateishi
    Department of Radiology, Yokohama City University Graduate School of Medicine, 3 9, Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Pediatr Radiol 40:1781-8. 2010
    ..The clinical validity of (18)F-FDG positron emission tomography (PET) has not been evaluated in juvenile idiopathic arthritis (JIA)...
  83. ncbi N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species
    Hiroaki Goto
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
    Int J Hematol 78:219-25. 2003
    ..Our findings suggest that ROS play a significant role in the antileukemia effect of 4-HPR and that the glutathione level in leukemias may be associated the sensitivity of the cells to 4-HPR...
  84. ncbi Urinary beta 2-microglobulin in premature infants with chorioamnionitis and chronic lung disease
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
    J Pediatr 143:120-2. 2003
    ..We propose that an elevated urinary beta(2)-MG can indicate a fetal inflammatory response and identify neonates at risk for the development of CLD...
  85. ncbi Latent cerebral hypoperfusion in a boy with persistent nephrotic syndrome
    Shu Ichi Ito
    Department of Pediatrics, Yokohama City University Medical Center, 4 57, Urafune cho, Minami Ku, 232 0024 Yokohama, Japan
    Brain Dev 24:780-3. 2002
    ..In our patient, cerebral hypoperfusion might have been associated with his mental problems, physical problems, and delayed development of speech...
  86. ncbi Amelioration of steroids and cyclosporine-resistant nephrotic syndrome by pravastatin
    Shuichi Ito
    Children s Medical Center, Yokohama City University Medical Center, Yokohama 232 0024, Japan
    Pediatr Nephrol 22:603-6. 2007
    ..Furthermore, the anti-inflammatory and immuno-modulatory effects, recently attributed to statins, may also have been involved in the improvement experienced by our patient...
  87. ncbi Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology
    Shuichi Ito
    Children s Medical Center, Yokohama City University Medical Center, 4 57, Urafune cho, Minami Ku, Yokohama, 232 0024, Japan
    Pediatr Nephrol 22:301-5. 2007
    ..He has not suffered a relapse of TMA or an allograft rejection for 4 years. IVIG might be an option for some patients with TMA of unknown etiology refractory to conventional treatment...
  88. ncbi Blood flow velocities in the anterior cerebral artery and basilar artery in asphyxiated infants
    Shigeru Nishimaki
    Department of Pediatrics, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa 236 0004, Japan
    J Ultrasound Med 27:955-60. 2008
    ....
  89. ncbi Kawasaki disease after burns
    Shuichi Ito
    Department of Pediatrics, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama, Japan
    Eur J Pediatr 165:340-1. 2006
  90. ncbi Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient
    Yukoh Aihara
    Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Int 47:616-21. 2005
    ..We experienced carbamazepine-induced HS in a 14-year-old boy, who had cefaclor-induced cutaneous eruptions 15 months later. To clarify the mechanisms of HS and the differences between two diseases we studied this case in detail...
  91. ncbi Glomerulonephritis in children with mixed connective tissue disease
    S Ito
    Department of Pediatrics, Yokohama City University Medical Center, Urafunecho 4 57, Minamiku, Yokohama, Kanagawa, 232 0024 Japan
    Clin Nephrol 66:160-5. 2006
    ..We examined the histopathological characteristics of juvenile MCTD nephritis, the importance of renal biopsy and the implications of hypocomplementemia in our patients and reported cases of MCTD...
  92. ncbi Transient neonatal diabetes mellitus in extremely preterm infant
    S Nishimaki
    Department of Paediatrics, Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama, Kanagawa, 236 0004, Japan
    Arch Dis Child Fetal Neonatal Ed 93:F240-1. 2008
    ..This case suggests that (a) insufficient insulin secretion started at least from the second trimester of the pregnancy; (b) the duration needed for recovery of insulin secretion was not dependent on the maturity...
  93. ncbi Epidemiological study of a food-borne outbreak of enterotoxigenic Escherichia coli O25:NM by pulsed-field gel electrophoresis and randomly amplified polymorphic DNA analysis
    T Mitsuda
    Division of Clinical Laboratory Medicine, School of Medicine, Yokohama City University, Japan
    J Clin Microbiol 36:652-6. 1998
    ..Results suggest that this outbreak was food borne. The molecular biology-based epidemiological techniques used in this study were useful in characterizing the causal agent in this food-borne epidemic...
  94. ncbi Usefulness of serum fibrinogen degradation product-E in sporadic cases of classical hemolytic uremic syndrome
    Y Aihara
    Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan
    Pediatr Int 42:523-7. 2000
    ..Recently, we experienced a sporadic case of typical HUS caused by Stx-producing E. coli O157:H7 and detected, at the prodromal stage, a high level of serum fibrin/fibrinogen degradation product-E (FDP-E) fraction...
  95. ncbi Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia
    Y Aihara
    Department of Pediatrics, Yokohama City University, School of Medicine, Yokohama, Japan
    J Interferon Cytokine Res 18:561-3. 1998
    ..Furthermore, this case demonstrates that caution must be observed in administering rIFN-gamma to genetically predisposed patients...
  96. ncbi The influence of methicillin-resistant Staphylococcus aureus (MRSA) carriers in a nursery and transmission of MRSA to their households
    T Mitsuda
    Department of Pediatrics, School of Medicine, Yokohama City University, Japan
    J Hosp Infect 42:45-51. 1999
    ..We recommend that healthcare providers should be examined for MRSA if an MRSA epidemic occurs in a hospital. The families of any such carriers should also be examined for MRSA...
  97. ncbi Molecular epidemiological study of Haemophilus influenzae serotype b strains obtained from children with meningitis in Japan
    T Mitsuda
    Division of Clinical Laboratory Medicine, School of Medicine, Yokohama City University, 3 9 Fukuura, Kanazawa Ku, Yokohama City, 236 0004, Japan
    J Clin Microbiol 37:2548-52. 1999
    ..The genotyping of clinically isolated Hib strains may help to elucidate transmission routes in community infections, endemicity, and the reasons for vaccine failure...
  98. ncbi Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction
    Y Aihara
    Department of Paediatrics, Yokohama City University Medical Centre, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Br J Dermatol 149:165-9. 2003
    ..This case might contribute to the understanding of the pathophysiology of HS...
  99. ncbi Increased chemosensitivity and elevated reactive oxygen species are mediated by glutathione reduction in glutamine deprived neuroblastoma cells
    Sakurako Izaki
    Yokohama City University School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama City, 236 0004, Japan
    J Cancer Res Clin Oncol 134:761-8. 2008
    ..To evaluate the effects of glutamine concentrations, cell growth, GSH levels, oxidative stress, and chemosensitivity were evaluated in neuroblastoma cell lines...
  100. ncbi [Influenza-associated encephalopathy--pathophysiology and disease mechanisms]
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine
    Nippon Rinsho 61:1953-8. 2003
    ..The disruption of blood-brain barrier progresses to the systemic cytokine storm, resulting in DIC and MOF...
  101. ncbi [Interleukin-6 as a pathogenic factor of systemic-onset juvenile idiopathic arthritis]
    Shumpei Yokota
    Department of Pediatrics, Yokohama City University School of Medicine
    Nihon Rinsho Meneki Gakkai Kaishi 31:99-103. 2008
    ..Basic science will help us to save the children, and clinical science also will promote the basic science in turn...